A broad-spectrum antifungal from the marine sponge Hyrtios erecta

International Journal of Antimicrobial Agents

Volumn 9, Issue 3, 1998, Pages 147-152

  Pettit, Robin K ^a   McAllister, Shane C ^b   Pettit, George R ^a   Herald, Cherry L ^a   Johnson, J Morris ^b   Cichacz, Zbigniew A ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Antifungal susceptibility; Opportunistic fungi; Spongistatin

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; KETOCONAZOLE; SPONGISTATIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MITOSIS; MORPHOGENESIS; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SPONGE;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, MICROBIAL; ETHERS, CYCLIC; FUNGI; LACTONES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PORIFERA;

EID: 0031881651     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(97)00044-7     Document Type: Article

References (20)

1. Flam F. Chemical prospectors scour the seas for promising drugs. Science. 266:1994;1324-1325.
2. Pettit G.R. Marine animal and terrestrial plant anticancer constituents. Pure Appl Chem. 66:1994;2271-2281.
3. Pettit G.R. Progress in the discovery of biosynthetic anticancer agents. J Nat Prod. 59:1996;812-821.
4. Pettit G.R., Cichacz Z.A., Gao F., Herald C.L., Boyd M.R. Isolation and structure of the remarkable human cancer cell growth inhibitors spongistatins 2 and 3 from an Eastern Indian Ocean Spongia sp. J Chem Soc Chem Commun. 14:1993;1166-1168.
5. Pettit G.R., Cichacz Z.A., Herald C.L., Boyd M.R., Schmidt J.M., Hooper J.N.A. Isolation and structure of spongistatin 1. J Org Chem. 58:1993;1302-1304.
6. Pettit G.R., Herald C.L., Cichacz Z.A.et al. Antineoplastic agents 293. The exceptional human cancer cell growth inhibitors spongistatins 6 and 7. Nat Prod Lett. 3:1993;239-244.
7. Pettit G.R., Herald C.L., Cichacz Z.A.et al. Isolation and structure of the powerful human cancer cell growth inhibitors spongistatins 4 and 5 from an African Spirastrella spinispirulifera (Porifera). J Chem Soc Chem Commun. 24:1993;1805-1807.
8. The National Nosocomial Infections Surveillance System, Beck-Sague C.M., Jarvis W.R. Secular trends in the epidemiology of nosocomial infections in the US, 1980-1990. J Infect Dis. 167:1993;1247-1251.
9. McCann J. Deadly fungal infections spreading in cancer patients. J Natl Cancer Inst. 87:1995;1434-1436.
10. Ampel N.M. Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis. 2:1996;109-116.
11. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th edn: Approved Standard M2-A6. NCCLS, Wayne, PA, 1997.
12. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Wayne, PA, 1997.
13. Espinel-Ingroff A., Bartlett M., Bowden R. Multicenter evaluation of a proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol. 35:1997;139-143.
14. Hazen K.C. New and emerging yeast pathogens. Clin Microbiol Rev. 8:1995;462-478.
15. Vartivarian S.E., Anaissie E.J., Bodey G.P. Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management. Clin Infect Dis. 17(Suppl. 2):1993;S487-S491.
16. Hamel E. Interactions of tubulin with small ligands. In: Avila J, editor. Microtubule Proteins. Boca Raton, FL: CRC Press, 1990:89-191.
17. Bai R., Friedman S.J., Pettit G.R., Hamel E. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia: Interaction with tubulin and effects on cellular microtubules. Biochem Pharmacol. 43:1993;2637-2645.
18. Bai R., Paull K.D., Herald C.L., Malspeis L., Pettit G.R., Hamel E. Halichondrin B and homohalichondrin B, marine natural products binding in the Vinca domain of tubulin: Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J Biol Chem. 266:1991;15882-15889.
19. Bai R., Cichacz Z.A., Herald C.L., Pettit G.R., Hamel E. Spongistatin 1, a highly cytotoxic, sponge-derived marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol Pharmacol. 44:1993;757-766.
20. Bai R., Taylor G.F., Cichacz Z.A. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the Vinca domain. Biochemistry. 34:1995;9714-9721.